News
Landmark Study Demonstrates Lower Rate of Inappropriate Shocks in Patients with Sorin Dual Chamber ICD Devices
May 11, 2013 10:00 am | by The Associated Press | CommentsDENVER--(BUSINESS WIRE)--May 11, 2013--Sorin Group (MIL:SRN), (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, announced findings from the landmark OPTION study 1 demonstrating that patients with Sorin dual-chamber implantable cardioverter...
Background Noise in the Operating Room Can Impair Surgical Team Communication
May 10, 2013 4:43 pm | by American College of Surgeons | CommentsAmbient background noise—whether it is the sound of loud surgical equipment, talkative team members, or music—is a patient and surgical safety factor that can affect auditory processing among surgeons and the members of their team in the operating room (OR), according to a new study that appears in the May issue of the Journal of the American College of Surgeons.
Data Show Medtronic-Exclusive LIA Software Detects Non-Medtronic Lead Issues at a Greater Rate Than Standard Impedance Monitoring
May 10, 2013 4:06 pm | by The Associated Press | CommentsMINNEAPOLIS and DENVER - May 10, 2013 - Data presented today at Heart Rhythm 2013, the Heart Rhythm Society's 34th Annual Scientific Sessions, show that Medtronic, Inc. (NYSE:MDT) Lead Integrity Alert (LIA) software detected pace/sense lead issues in non-Medtronic leads at a...
Nanostim Announces Preliminary Results from LEADLESS Study in Late-Breaking Clinical Trial at Heart Rhythm 2013
May 10, 2013 3:42 pm | by The Associated Press | CommentsSUNNYVALE, Calif.--(BUSINESS WIRE)--May 10, 2013--Nanostim, Inc., a privately-owned developer of miniaturized, leadless cardiac pacemakers (LCP), today announced preliminary results from its LEADLESS study during the late breaking clinical trial presentations at Heart Rhythm 2013, the Heart Rhythm...
Sorin Group Announces FDA Approval and U.S. Launch OF SMARTVIEW Remote Monitoring Solution for Patients with Implanted Cardiac Defibrillators
May 10, 2013 12:04 pm | by The Associated Press | CommentsDENVER--(BUSINESS WIRE)--May 10, 2013--Sorin Group (MIL:SRN), (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, today announced it received FDA approval for and is beginning the U.S. launch of the SMARTVIEW™ remote monitoring solution for...
Medtronic Issues Statement on iPad Interference Study
May 10, 2013 11:02 am | by Medtronic | CommentsMedtronic's current internal analysis and testing shows iPad technology presents no risk of electromagnetic interference with Medtronic implantable cardiac rhythm devices when used per manufacturer's instructions. However, as a precaution, patients implanted with a pacemaker or ICD are advised to follow Apple and Medtronic labeling recommendations and maintain a distance of six inches between the iPad and implanted device.
Building Protocells from Inorganic Nanoparticles
May 10, 2013 11:00 am | by University of Bristol | CommentsResearchers at the University of Bristol have led a new enquiry into how extremely small particles of silica (sand) can be used to design and construct artificial protocells in the laboratory. The work is described in an article published in Nature Chemistry.
Flawed Diamonds Promise Sensory Perfection
May 10, 2013 10:48 am | by Lawrence Berkeley National Laboratory | CommentsFrom brain to heart to stomach, the bodies of humans and animals generate weak magnetic fields that a supersensitive detector could use to pinpoint illnesses, trace drugs – and maybe even read minds. Sensors no bigger than a thumbnail could map gas deposits underground, analyze chemicals, and pinpoint explosives that hide from other probes.
Biomaterial Shows Promise for Type 1 Diabetes Treatment
May 10, 2013 10:41 am | by Georgia Tech | CommentsResearchers have made a significant first step with newly engineered biomaterials for cell transplantation that could help lead to a possible cure for Type 1 diabetes, which affects about 3 million Americans. Georgia Tech engineers and Emory University clinicians have successfully engrafted insulin-producing cells into a diabetic mouse model, reversing diabetic symptoms in the animal in as little as 10 days.
Operating Without Interrupting Warfarin Reduces Risk of Bleeding After Cardiac Device Surgery
May 10, 2013 10:21 am | by University of Ottawa Heart Institute | CommentsA new Canadian study shows that operating without interrupting warfarin treatment at the time of cardiac device surgery is safe and markedly reduces the incidence of clinically significant hematomas compared to the current standard of care. The new findings were released today at Heart Rhythm 2013, the Heart Rhythm Society's 34th Annual Scientific Sessions.
Life Care Medical Devices Ltd Announces Addition Of Dublin, Ireland Based European Subsidiary
May 10, 2013 7:04 am | by The Associated Press | CommentsLife Care Medical Devices Ltd (OTCBB:LCMD) today announced the opening of their European subsidiary offices in Dublin, Ireland. Life Care Medical Devices Ltd, Ireland will manage all aspects of the company's European business. "With a strong, solid history in the medical device arena,...
Canada’s Sunnybrook Health Sciences Centre Joins Elekta and Philips Research Consortium on MRI-Guided Radiation Therapy
May 10, 2013 1:46 am | by The Associated Press | CommentsSTOCKHOLM, Sweden--(BUSINESS WIRE)--May 10, 2013--Regulatory News: Elekta (NSE: EKTAb) and Royal Philips Electronics (NYSE: PHG, AEX: PHIA) announced today that Sunnybrook Health Sciences Centre (Toronto, Canada) will join their growing consortium to validate the clinical potential of MRI-guided...
Globus Medical Launches FORTIFY® I Integrated Expandable Corpectomy System
May 9, 2013 7:06 pm | by The Associated Press | CommentsAUDUBON, Pa.--(BUSINESS WIRE)--May 9, 2013--Globus Medical, Inc. (NYSE: GMED), a leading spinal implant manufacturer, today announced the launch of FORTIFY ® I, an expandable corpectomy spacer with integrated screws for further stability in addition to supplemental fixation. “The FORTIFY ® I...
St. Jude Medical Announces Results from Independent Analysis of Optim-Insulated Defibrillation Leads in Late-Breaking Clinical Trial Session at Heart Rhythm 2013
May 9, 2013 1:55 pm | by The Associated Press | CommentsST. PAUL, Minn.--(BUSINESS WIRE)--May 9, 2013--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the Population Health Research Institute (PHRI), an academic health science research institute, has conducted a further independent analysis of data received from...
New Four-Year Data From Boston Scientific Demonstrated WATCHMAN Device Was Superior To Warfarin For Mortality And Primary Efficacy In Patients With Atrial Fibrillation In Long Term Follow-Up Of The PROTECT AF Trial
May 9, 2013 12:02 pm | by The Associated Press | CommentsBoston Scientific Corporation (NYSE: BSX) reports that the four-year follow-up data from the PROTECT AF clinical trial demonstrated the WATCHMAN@ Left Atrial Appendage (LAA) Closure device was statistically superior to warfarin for preventing cardiovascular death, all-cause stroke and systemic...
